prostate cancer. Malignant neoplasm of prostate
Conditions
Interventions
Intervention 1: All patients in intervention group take powder of Malva sylvestris in 5mg packets twice a day orally with a glass of water. Intervention 2: All patients in control group take powder of
Prevention
Placebo
All patients in intervention group take powder of Malva sylvestris in 5mg packets twice a day orally with a glass of water.
All patients in control group take powder of placebo which is designed for this study in 5mg packets twice a day orally with a glass of water.
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients who are planed radiotherapy with impression of prostate adenocarcinema and signed informed consent, those who are able to Express dysuria and do not have not have foley catheter. exclusion criteria: Drug or placebo sensitivity and positive urine culture indicative of infection.
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Dysuria severity. Timepoint: Weekly during radiotherapy. Method of measurement: Visual Analog Scale 0-10. | — |
Primary
| Measure | Time frame |
|---|---|
| Dysuria. Timepoint: Weekly during radiotherapy. Method of measurement: A modified IPSS (International Prostate Symptom Score). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Mohammad Jaladat
Tehran University of Medical Sciences, department-of-traditional-medicine
Outcome results
None listed